{"instruction": "You are an expert in event extraction. Please extract events from the input that conform to the schema definition. Return an empty list for events that do not exist, and return NAN for arguments that do not exist. If an argument has multiple values, please return a list. Respond in the format of a JSON string.", "schema": [{"event_type": "adverse event", "trigger": true, "arguments": ["Treatment", "Effect", "Subject.Disorder", "Subject.Race", "Subject.Gender", "Treatment.Duration", "Treatment.Dosage", "Treatment.Drug", "Subject.Population", "Treatment.Disorder"]}, {"event_type": "potential therapeutic event", "trigger": true, "arguments": ["Treatment.Route", "Subject.Population", "Treatment.Time_elapsed", "Treatment.Freq", "Subject", "Treatment.Disorder", "Combination.Drug", "Subject.Race", "Treatment.Duration", "Treatment.Dosage", "Subject.Gender", "Treatment.Drug", "Effect", "Subject.Age", "Treatment", "Subject.Disorder"]}], "input": "In phase III clinical trials, the telithromycin 800 mg once-daily dose has been shown to provide close to the maximum antimicrobial activity against S. pneumoniae, Haemophilus influenzae and Staphylococcus aureus in patients with community-acquired pneumonia."}
{"adverse event": [], "potential therapeutic event": [{"trigger": "provide ", "arguments": {"Treatment.Route": "NAN", "Subject.Population": "NAN", "Treatment.Time_elapsed": "NAN", "Treatment.Freq": "once-daily", "Subject": "patients with community-acquired pneumonia", "Treatment.Disorder": ["Haemophilus influenzae", "S. pneumoniae", "pneumonia", "Staphylococcus aureus"], "Combination.Drug": "NAN", "Subject.Race": "NAN", "Treatment.Duration": "NAN", "Treatment.Dosage": "800 mg", "Subject.Gender": "NAN", "Treatment.Drug": "telithromycin", "Effect": "NAN", "Subject.Age": "NAN", "Treatment": "telithromycin 800 mg once-daily dose", "Subject.Disorder": "NAN"}}]}